Best Paper Award

The Antibodies Best Paper Award is granted annually to highlight publications of high quality, scientific significance, and extensive influence. The evaluation committee members choose one article of exceptional quality that has been published in the journal in the previous year and announce it online by the end of July.

The Prize:
– One research article/review is selected.
– Each winner receives CHF 500, a certificate, and a free voucher for article processing fees valid for one year.

 
Antibodies Best Paper Award
 

Eligibility and Requirements

– All papers published in Antibodies are eligible (both regular and Special Issue submissions).

Selection Criteria

– Scientific merit and broad impact;
– Originality of the research objectives and/or the ideas presented;
– Creativity in the study design or uniqueness in the approaches and concepts;
– Clarity of presentation;
– Citations and downloads.

 
Past Winners
 
Year: 

Winner

19 pages, 1303 KB  
Review
New Insights into Pathogenesis and Treatment of ANCA-Associated Vasculitis: Autoantibodies and Beyond
by Marino Paroli, Chiara Gioia and Daniele Accapezzato
Antibodies 2023, 12(1), 25; https://doi.org/10.3390/antib12010025 - 21 Mar 2023

Award Committee

Prof. Arne Skerra Chairperson
Prof. Dr. Serge Muyldermans
VUB
Prof. Mattias Collin
Lund University

Winner

25 pages, 1041 KB  
Review
Alternative Routes of Administration for Therapeutic Antibodies—State of the Art
by Aubin Pitiot, Nathalie Heuzé-Vourc’h and Thomas Sécher
Antibodies 2022, 11(3), 56; https://doi.org/10.3390/antib11030056 - 26 Aug 2022

Award Committee

Prof. Arne Skerra Chairperson
Dr. Pablo Engel
Department of Biomedical Sciences
Prof. Dr. Buyong Ma
Prof. Mattias Collin
Lund University

Winner

Mark L. Chiu
Drug Product Development Science, Janssen Research & Development, LLC, Malvern, PA 19355, USA
Back to TopTop